rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Patrick D. Spangler

Director

Company insider

Files Form 4 as: Director, OptimizeRx; Director, Urologix; Chief Financial Officer, Epocrates; Sr. VP and CFO, ev3.

Every Form 4 they filed

In numbers

Trades disclosed
60
Buys
3
Sells
4
Bought
$945
Sold
$759K
Companies
4
Companies where not an officer
2
First trade
9 May 2006
Last trade
9 Jun 2026
Last filed
10 Jun 2026

Companies traded

Where they are an officer
EpocratesOfficer · last 20 Jan 20120 buys · 0 sells
ev3Officer · last 17 Nov 20080 buys · 2 sells
Everywhere else they filed: board seats, 10% stakes, other companies
OPRX OptimizeRxDirector · Business Services · last 9 Jun 20263 buys · 2 sells
UrologixDirector · last 6 Nov 20140 buys · 0 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
10Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
9 Jun 2026filed 10 Jun 2026OPRX OptimizeRxBusiness ServicesSEC FORM 4 Code A—34,517 at $0.00filing
9 Jun 2026filed 10 Jun 2026OPRX OptimizeRxBusiness ServicesSEC FORM 4 Code A—34,517 at $0.00filing
28 Aug 2025filed 11 Sep 2025OPRX OptimizeRxBusiness ServicesSEC FORM 4 Sold$194K11,120 at $17.49filing
11 Jun 2025filed 12 Jun 2025OPRX OptimizeRxBusiness ServicesSEC FORM 4 Code A—9,868 at $0.00filing
7 Jun 2024filed 11 Jun 2024OPRX OptimizeRxBusiness ServicesSEC FORM 4 Code A—13,286 at $0.00filing
5 Jun 2024filed 11 Jun 2024OPRX OptimizeRxoption or derivative · Business ServicesSEC FORM 4 Code M—10,061 at $0.00filing
5 Jun 2024filed 11 Jun 2024OPRX OptimizeRxBusiness ServicesSEC FORM 4 Code M—10,061 at $0.00filing
7 Jun 2023filed 18 Aug 2023OPRX OptimizeRxoption or derivative · Business ServicesSEC FORM 4 Code M—4,637 at $0.00filing
7 Jun 2023filed 18 Aug 2023OPRX OptimizeRxoption or derivative · Business ServicesSEC FORM 4 Code A—10,061 at $0.00filing
7 Jun 2023filed 18 Aug 2023OPRX OptimizeRxBusiness ServicesSEC FORM 4 Code M—4,637 at $0.00filing
31 Mar 2023filed 3 Apr 2023OPRX OptimizeRxoption or derivative · Business ServicesSEC FORM 4 Code M—657 at $0.00filing
31 Mar 2023filed 3 Apr 2023OPRX OptimizeRxBusiness ServicesSEC FORM 4 Code M—657 at $0.00filing
30 Dec 2022filed 4 Jan 2023OPRX OptimizeRxoption or derivative · Business ServicesSEC FORM 4 Code M—409 at $0.00filing
30 Dec 2022filed 4 Jan 2023OPRX OptimizeRxBusiness ServicesSEC FORM 4 Code M—409 at $0.00filing
29 Sep 2022filed 30 Sep 2022OPRX OptimizeRxoption or derivative · Business ServicesSEC FORM 4 Code M—334 at $0.00filing
29 Sep 2022filed 30 Sep 2022OPRX OptimizeRxBusiness ServicesSEC FORM 4 Code M—334 at $0.00filing
9 Jun 2022filed 13 Jun 2022OPRX OptimizeRxoption or derivative · Business ServicesSEC FORM 4 Code A—4,637 at $0.00filing
30 Mar 2022filed 1 Apr 2022OPRX OptimizeRxoption or derivative · Business ServicesSEC FORM 4 Code A—657 at $0.00filing
30 Dec 2021filed 3 Jan 2022OPRX OptimizeRxoption or derivative · Business ServicesSEC FORM 4 Code A—409 at $0.00filing
11 Nov 2021filed 15 Nov 2021OPRX OptimizeRxBusiness ServicesSEC FORM 4 Sold$528K6,252 at $84.38filing

News

No headline names them, or the companies they trade most, lately.

Sectors

Industrials5
Not placed2

Buys in green, sells in red, by the company’s sector.

Related people

Nobody else traded the same names lately.